Shadid Omar, Seth Ishith, Cuomo Roberto, Rozen Warren M, Marcaccini Gianluca
Department of Plastic and Reconstructive Surgery, Peninsula Health, 2 Hastings Road, Melbourne, VIC 3199, Australia.
Plastic and Reconstructive Surgery, Department of Medicine, Surgery and Neuroscience, University of Siena, 53100 Siena, Italy.
J Clin Med. 2025 Jun 27;14(13):4574. doi: 10.3390/jcm14134574.
Microsurgery is a highly complex and technically demanding field within reconstructive surgery, with outcomes heavily dependent on meticulous planning, precision, and postoperative monitoring. Over the last five years, artificial intelligence (AI) has emerged as a transformative tool across all phases of microsurgical care, offering new capabilities in imaging analysis, intraoperative decision support, and outcome prediction. A comprehensive narrative review was conducted to evaluate the peer-reviewed literature published between 2020 and May 2025. Multiple databases, including PubMed, Embase, Cochrane, Scopus, and Web of Science, were searched using combinations of controlled vocabulary and free-text terms relating to AI and microsurgery. Studies were included if they described AI applications during the preoperative, intraoperative, or postoperative phases of microsurgical care in human subjects. Using predictive models, AI demonstrated significant utility in preoperative planning through automated perforator mapping, flap design, and individualised risk stratification. AI-enhanced augmented reality and perfusion analysis tools improved precision intraoperatively, while innovative robotic platforms and intraoperative advisors showed early promise. Postoperatively, mobile-based deep learning applications enabled continuous flap monitoring with sensitivities exceeding 90%, and AI models accurately predicted surgical site infections, transfusion needs, and long-term outcomes. Despite these advances, most studies relied on retrospective single-centre data, and large-scale, prospective validation remains limited. AI is poised to enhance microsurgical precision, safety, and efficiency. However, its integration is challenged by data heterogeneity, generalisability concerns, and the need for human oversight in nuanced clinical scenarios. Standardised data collection and multicentre collaboration are vital for robust, equitable AI deployment. With careful validation and implementation, AI holds the potential to redefine microsurgical workflows and improve patient outcomes across diverse clinical settings.
显微外科是重建外科中一个高度复杂且技术要求极高的领域,其手术效果在很大程度上取决于精心的规划、精准度以及术后监测。在过去五年中,人工智能(AI)已成为显微外科护理各阶段的变革性工具,在影像分析、术中决策支持和结果预测方面提供了新的能力。我们进行了一项全面的叙述性综述,以评估2020年至2025年5月期间发表的同行评审文献。使用与人工智能和显微外科相关的控制词汇和自由文本术语组合,对包括PubMed、Embase、Cochrane、Scopus和科学网在内的多个数据库进行了检索。如果研究描述了人工智能在人类受试者显微外科护理的术前、术中或术后阶段的应用,则将其纳入。通过预测模型,人工智能在术前规划中通过自动穿支血管映射、皮瓣设计和个体化风险分层显示出显著的效用。人工智能增强的增强现实和灌注分析工具提高了术中的精准度,而创新的机器人平台和术中顾问则显示出早期的前景。术后,基于移动设备的深度学习应用程序能够对皮瓣进行连续监测,敏感度超过90%,并且人工智能模型能够准确预测手术部位感染、输血需求和长期结果。尽管取得了这些进展,但大多数研究依赖回顾性单中心数据,大规模的前瞻性验证仍然有限。人工智能有望提高显微外科的精准度、安全性和效率。然而,其整合面临着数据异质性、普遍性问题以及在细微临床场景中需要人工监督的挑战。标准化的数据收集和多中心合作对于强大、公平的人工智能部署至关重要。通过仔细的验证和实施,人工智能有潜力重新定义显微外科工作流程,并在不同临床环境中改善患者的治疗效果。
Cochrane Database Syst Rev. 2022-5-20
Cochrane Database Syst Rev. 2020-10-19
JBI Database System Rev Implement Rep. 2016-4
Cochrane Database Syst Rev. 2013-11-15
JBI Database System Rev Implement Rep. 2016-4
Therap Adv Gastroenterol. 2025-6-23
Cochrane Database Syst Rev. 2023-11-15
Cochrane Database Syst Rev. 2017-8-22
PLOS Digit Health. 2025-6-5
Mayo Clin Proc Digit Health. 2024-12-18
J Clin Med. 2024-12-23
Front Med Technol. 2024-11-28
JPRAS Open. 2024-9-14
J Clin Med. 2024-9-6